Poseida Therapeutics (PSTX) Appoints Cynthia Collins to its Board

Go back to Poseida Therapeutics (PSTX) Appoints Cynthia Collins to its Board

MaxCyte Appoints Cynthia Collins to its Board of Directors

October 15, 2024 8:05 AM EDT

ROCKVILLE, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based... More